These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29346327)

  • 1. Enhanced Isotopic Ratio Outlier Analysis (IROA) Peak Detection and Identification with Ultra-High Resolution GC-Orbitrap/MS: Potential Application for Investigation of Model Organism Metabolomes.
    Qiu Y; Moir RD; Willis IM; Seethapathy S; Biniakewitz RC; Kurland IJ
    Metabolites; 2018 Jan; 8(1):. PubMed ID: 29346327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotopic Ratio Outlier Analysis of the S. cerevisiae Metabolome Using Accurate Mass Gas Chromatography/Time-of-Flight Mass Spectrometry: A New Method for Discovery.
    Qiu Y; Moir R; Willis I; Beecher C; Tsai YH; Garrett TJ; Yost RA; Kurland IJ
    Anal Chem; 2016 Mar; 88(5):2747-54. PubMed ID: 26820234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotopic ratio outlier analysis improves metabolomics prediction of nitrogen treatment in maize.
    Vlahakis C; Hazebroek J; Beecher C; de Jong F
    Phytochemistry; 2019 Aug; 164():130-135. PubMed ID: 31128492
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Clendinen CS; Stupp GS; Wang B; Garrett TJ; Edison AS
    Curr Metabolomics; 2016 Aug; 4(2):116-120. PubMed ID: 28090435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics Benefits from Orbitrap GC-MS-Comparison of Low- and High-Resolution GC-MS.
    Stettin D; Poulin RX; Pohnert G
    Metabolites; 2020 Apr; 10(4):. PubMed ID: 32260407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution gas chromatography/mass spectrometry metabolomics of non-human primate serum.
    Misra BB; Bassey E; Bishop AC; Kusel DT; Cox LA; Olivier M
    Rapid Commun Mass Spectrom; 2018 Sep; 32(17):1497-1506. PubMed ID: 29874398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of environmental contaminants in honeybees using GC-TOF-MS and GC-Orbitrap-MS.
    Gómez-Ramos MM; Ucles S; Ferrer C; Fernández-Alba AR; Hernando MD
    Sci Total Environ; 2019 Jan; 647():232-244. PubMed ID: 30081361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Resolution GC-Orbitrap-MS Metabolomics Using Both Electron Ionization and Chemical Ionization for Analysis of Human Plasma.
    Misra BB; Olivier M
    J Proteome Res; 2020 Jul; 19(7):2717-2731. PubMed ID: 31978300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance.
    Frison G; Zamengo L; Zancanaro F; Tisato F; Traldi P
    Rapid Commun Mass Spectrom; 2016 Jan; 30(1):151-60. PubMed ID: 26661982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical Characterization of 3-MeO-PCP and 3-MMC in Seized Products and Biosamples: The Role of LC-HRAM-Orbitrap-MS and Solid Deposition GC-FTIR.
    Frison G; Zancanaro F; Frasson S; Quadretti L; Agnati M; Vlassich F; Gagliardi G; Salerno TMG; Donato P; Mondello L
    Front Chem; 2020; 8():618339. PubMed ID: 33628763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Isotopologue Workflows and Simultaneous Multidimensional Separations to Detect, Identify, and Validate Metabolites in Untargeted Analyses.
    Dodds JN; Wang L; Patti GJ; Baker ES
    Anal Chem; 2022 Feb; 94(5):2527-2535. PubMed ID: 35089687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance.
    Frison G; Odoardi S; Frasson S; Sciarrone R; Ortar G; Romolo FS; Strano Rossi S
    Rapid Commun Mass Spectrom; 2015 Jul; 29(13):1196-204. PubMed ID: 26395784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-targeted Gas Chromatography Orbitrap Mass Spectrometry qualitative and quantitative analysis of semi-volatile organic compounds in indoor dust using the Regions of Interest Multivariate Curve Resolution chemometrics procedure.
    Pourasil RSM; Cristale J; Lacorte S; Tauler R
    J Chromatogr A; 2022 Apr; 1668():462907. PubMed ID: 35276410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Use of Gas Chromatography Coupled to Chemical Ionization Mass Spectrometry (GC-CI-MS) for Stable Isotope Labeling in Metabolomics.
    Capellades J; Junza A; Samino S; Brunner JS; Schabbauer G; Vinaixa M; Yanes O
    Anal Chem; 2021 Jan; 93(3):1242-1248. PubMed ID: 33369389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive screening of 63 coloring agents in cosmetics using matrix solid-phase dispersion and ultra-high-performance liquid chromatography coupled with quadrupole-Orbitrap high-resolution mass spectrometry.
    Chen M; Bai H; Zhai J; Meng X; Guo X; Wang C; Wang P; Lei H; Niu Z; Ma Q
    J Chromatogr A; 2019 Apr; 1590():27-38. PubMed ID: 30630619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolite identification by data-dependent accurate mass spectrometric analysis at resolving power of 60,000 in external calibration mode using an LTQ/Orbitrap.
    Lim HK; Chen J; Sensenhauser C; Cook K; Subrahmanyam V
    Rapid Commun Mass Spectrom; 2007; 21(12):1821-32. PubMed ID: 17497624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in high resolution GC-MS technology: a focus on the application of GC-Orbitrap-MS in metabolomics and exposomics for FAIR practices.
    Misra BB
    Anal Methods; 2021 May; 13(20):2265-2282. PubMed ID: 33987631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of gas chromatography/quadrupole-Orbitrap mass spectrometry in support of pharmaceutical research and development.
    Baldwin S; Bristow T; Ray A; Rome K; Sanderson N; Sims M; Cojocariu C; Silcock P
    Rapid Commun Mass Spectrom; 2016 Apr; 30(7):873-80. PubMed ID: 26969929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.